BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2000
View Archived Issues
New agents for GI disorders patented by Byk Gulden
Read More
Inhibitors of PTP1B in early development at Merck
Read More
Proapoptotic and antiproliferative chroman-based compounds designed by RDF
Read More
Genentech makes progress on all fronts during first quarter
Read More
Polypeptides and their use for treating or diagnosing bacterial infections described by SB
Read More
Dual NOS inhibitors/antioxidants designed at SCRAS
Read More
Potential antiparkinsonian agents from Kyowa Hakko acting as adenosine A2A antagonists
Read More
CPI-1189 may provide neuroprotection via blockade of p38 MAPK phosphorylation
Read More
Japanese scientists synthesize new series of MMP inhibitors
Read More
Important European market introduction for RenaGel
Read More
Sankyo acquires expanded marketing rights to new antihyperlipidemic agent
Read More
Worldwide licensing agreement announced for MKC-733
Read More
Three products advance in Yamanouchi's clinical pipeline
Read More
Y-27632 demonstrates beneficial effects on hepatic fat-storing cells and hepatic fibrosis
Read More
Cortex and Shire enter agreement on CX-516 for treatment of ADHD
Read More
Genelabs discovers novel RNA-binding compounds
Read More
Cambridge Drug Discovery and Teijin to collaborate on novel lead compound development
Read More
Results of LeukArrest and Pafase clinical trials
Read More
EMEA issues warning and modified labeling for Viramune
Read More
Campath MAA accepted for review by European authorities
Read More
Discovery Therapeutics initiates phase II atrial fibrillation trial
Read More
Abbott and Chrysalis BioTechnology collaborate on Chrysalin development
Read More
Another mechanism of action of bacterial cell killing proposed for ramoplanin
Read More
Preliminary clinical data confirm positive effect of oral heparin dosage form
Read More
Bristol-Myers Squibb resubmits UFT NDA to FDA
Read More
New hope for patients suffering from Sjogren's syndrome: FDA approves cevimeline
Read More
Orion acquires worldwide rights to Nestorone as hormone replacement therapy
Read More